Home » Cellular Processes » Signal Transduction » Cytokine and NF-κB Signaling » NF-κB & IκB » Honokiol

Honokiol

Cat. No. 4590

Price and Availability

For Honokiol pricing & availability please select your country from the drop down menu:
Submit

By clicking submit you agree to accept a cookie from Tocris Bioscience. For details, please read our privacy and cookie policy.

Chemical Name: 5,3'-Diallyl-2,4'-dihydroxybiphenyl

Biological Activity

Anti-inflammatory, antioxidant, antitumor and antiangiogenic agent. Blocks NF-κB activation by a variety of stimuli, including TNF and okadaic acid. Shown to scavenge superoxide and peroxyl radicals. Also inhibits a variety of inflammatory responses.

Technical Data

M.Wt:

266.33

Formula:

C₁₈H₁₈O₂

Solubility:

Soluble to 100 mM in DMSO and to 100 mM in ethanol

Purity:

>98 %

Storage:

Store at +4°C

CAS No:

35354-74-6

The technical data provided above is for guidance only.
For batch specific data refer to the Certificate of Analysis.

Resources

Certificate of Analysis / Safety Data Sheet

Certificate of Analysis: View current batch

Safety Data Sheet: View Safety Data Sheet

References

Bai et al (2003) Honokiol, a small molecular weight natural product, inhibits angiogenesis in vitro and tumor growth in vivo. J.Biol.Chem. 278 35501. PMID: 12816951.

Ahn et al (2006) Honokiol potentiates apoptosis, suppresses osteoclastogenesis, and inhibits invasion through modulation of nuclear factor-κB activation pathway. Mol.Cancer Res. 4 621. PMID: 16966432.

Dikalov et al (2008) Honokiol is a potent scavenger of superoxide and peroxyl radicals. Biochem.Pharmacol. 76 589. PMID: 18640101.

Kim and Cho (2008) Anti-inflammatory effect of honokiol is mediated by PI3K/Akt pathway suppression. Acta Pharmacol.Sinica 29 113. PMID: 18158873.

If you know of a relevant citation for this product please let us know.

View Related Products by Target

Antioxidants Cytokine and NF-κB Signaling

NF-κB & IκB Transcription Factors

Keywords: Honokiol, supplier, anti-inflammatories, antioxidants, antitumor, antiangiogenics, nf-kb, nf-kappa, b, nf-κb, inhibitors

Quick Order

Find multiple products by catalog number

Cancer Research Guide

Request your free copy

Highlights over 350 products for cancer research. Request a copy or view PDF today.

Immunology Guide

Highlights over 150 products for immunology research. Request a copy or view PDF today.

New Therapies and Challenges in Asthma

Written by Peter J. Barnes

'New Therapies, Challenges, and Breakthroughs in Asthma' highlights key pathways and new therapies used to treat asthma, including those currently in clinical development.

NF-κB Pathway

Signals through the NF-κB pathway are important in the inflammation and the adaptive and innate immune response. View pathway or download PDF today.

New Product Guide

Highlights over 130 new products added in 2012. Request a copy or view PDF today.

New Products in this Area

Sulfasalazine

Inhibitor of NF-kB activation; also inhibits SXC

CID 2858522

Selectively inhibits PKC-induced NF-κB activation

Sign-up for new product e-alerts

20% Discount*

Potent, selective LRRK2 inhibitor

Potent LRRK2 inhibitor now available from Tocris Bioscience

Tocris is the first to launch GSK2578215A, licensed from GlaxoSmithKline, for the study of Parkinson's Disease.

* Terms & conditions